Your browser doesn't support javascript.
loading
Resection of primary lesion for patients with metastatic breast cancer: where are we now?
Hu, Qiancheng; Zhong, Xiaorong; Liu, Xu; Xie, Yuxin; Hu, Kejia; He, Ping; Lu, Donghao; Zheng, Hong.
Afiliación
  • Hu Q; Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
  • Zhong X; Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China; State Key Laboratory of Biotherapy, Laboratory of Tumor Molecular Diagnosis, West China Hospital, National Collaborative Innovation Center for Biotherapy, West Ch
  • Liu X; State Key Laboratory of Biotherapy, Laboratory of Tumor Molecular Diagnosis, West China Hospital, National Collaborative Innovation Center for Biotherapy, West China Medical School, Sichuan University, Chengdu 610041, China.
  • Xie Y; Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China; State Key Laboratory of Biotherapy, Laboratory of Tumor Molecular Diagnosis, West China Hospital, National Collaborative Innovation Center for Biotherapy, West Ch
  • Hu K; State Key Laboratory of Biotherapy, Laboratory of Tumor Molecular Diagnosis, West China Hospital, National Collaborative Innovation Center for Biotherapy, West China Medical School, Sichuan University, Chengdu 610041, China.
  • He P; Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China; Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Lu D; Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China; Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu 610041, China; Department of Medical Epidemiology and Biostatistics, Karolin
  • Zheng H; Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China; State Key Laboratory of Biotherapy, Laboratory of Tumor Molecular Diagnosis, West China Hospital, National Collaborative Innovation Center for Biotherapy, West Ch
Chin Clin Oncol ; 7(3): 24, 2018 Jun.
Article en En | MEDLINE | ID: mdl-30056726
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mastectomía Segmentaria / Mastectomía Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Chin Clin Oncol Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mastectomía Segmentaria / Mastectomía Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Chin Clin Oncol Año: 2018 Tipo del documento: Article País de afiliación: China